Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Tveden Gundesen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Bone Oncology|April 17, 2025
Treatment of myeloma bone disease: When, how often, and for how long?Michael Tveden Gundesen, Fredrik Schjesvold, Thomas Lund
Current Oncology Reports|January 29, 2019
Plasma Cell Leukemia: Definition, Presentation, and TreatmentMichael Tveden Gundesen, Thomas Lund, Hanne E H Moeller, et al.
European Journal of Haematology|April 1, 2025
Home-Based Daratumumab in Patients With Multiple MyelomaTine Rosenberg, Jannie Kirkegaard, Michael Tveden Gundesen, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 26, 2022
Home is best. Self-administration of subcutaneous Bortezomib at home in patients with multiple myeloma - A mixed method studyJannie Kirkegaard, Birgitte Wolf Lundholm, Tine Rosenberg, et al.
Hematology Reports|June 25, 2026
Digital Symptom Reporting for Treatment Readiness Before Daratumumab: A Blinded Prospective Study in Multiple MyelomaTine Rosenberg, Jannie Kirkegaard, Michael Tveden Gundesen, et al.
Oncotarget|January 16, 2024
Bone marrow adipocytes provide early sign for progression from MGUS to multiple myelomaBilal M El-Masri, Benedeta Leka, Fatima Mustapha, et al.
Journal of Neuro-Oncology|March 25, 2015
High levels of c-Met is associated with poor prognosis in glioblastomaStine Asferg Petterson, Rikke Hedegaard Dahlrot, Simon Kjær Hermansen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 27, 2023
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 StudyMarta Diaz-delCastillo, Michael Tveden Gundesen, Christian Walther Andersen, et al.
Cancers|December 9, 2023
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone DiseaseMartin Johansen, Mette Bøegh Levring, Kasper Stokbro, et al.
Haematologica|November 28, 2024
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myelomaAric Anloague, Hayley M Sabol, Japneet Kaur, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Bone Oncology|April 17, 2025
Treatment of myeloma bone disease: When, how often, and for how long?Michael Tveden Gundesen, Fredrik Schjesvold, Thomas Lund
Current Oncology Reports|January 29, 2019
Plasma Cell Leukemia: Definition, Presentation, and TreatmentMichael Tveden Gundesen, Thomas Lund, Hanne E H Moeller, et al.
European Journal of Haematology|April 1, 2025
Home-Based Daratumumab in Patients With Multiple MyelomaTine Rosenberg, Jannie Kirkegaard, Michael Tveden Gundesen, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 26, 2022
Home is best. Self-administration of subcutaneous Bortezomib at home in patients with multiple myeloma - A mixed method studyJannie Kirkegaard, Birgitte Wolf Lundholm, Tine Rosenberg, et al.
Hematology Reports|June 25, 2026
Digital Symptom Reporting for Treatment Readiness Before Daratumumab: A Blinded Prospective Study in Multiple MyelomaTine Rosenberg, Jannie Kirkegaard, Michael Tveden Gundesen, et al.
Oncotarget|January 16, 2024
Bone marrow adipocytes provide early sign for progression from MGUS to multiple myelomaBilal M El-Masri, Benedeta Leka, Fatima Mustapha, et al.
Journal of Neuro-Oncology|March 25, 2015
High levels of c-Met is associated with poor prognosis in glioblastomaStine Asferg Petterson, Rikke Hedegaard Dahlrot, Simon Kjær Hermansen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 27, 2023
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3-Month Results from an Open Label Phase 2 StudyMarta Diaz-delCastillo, Michael Tveden Gundesen, Christian Walther Andersen, et al.
Cancers|December 9, 2023
Novel Developments in the Treatment of Multiple Myeloma-Associated Bone DiseaseMartin Johansen, Mette Bøegh Levring, Kasper Stokbro, et al.
Haematologica|November 28, 2024
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myelomaAric Anloague, Hayley M Sabol, Japneet Kaur, et al.
Pageof 2